References
- Foley KM. Acute and chronic cancer pain syndromes. In: Doyle D, Hanks G, Cherny N, Calman K, eds. Oxford textbook of palliative medicine. 3rd ed. New York:Oxford University Press; 2004. p. 298-316.
- van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007;18:1437-49. https://doi.org/10.1093/annonc/mdm056
- Deandrea S, Corli O, Consonni D, Villani W, Greco MT, Apolone G. Prevalence of breakthrough cancer pain: a systematic review and pooled analysis of published literature. J Pain Symptom Manage 2014;47:57-76. https://doi.org/10.1016/j.jpainsymman.2013.02.015
- Hong SH, Roh SY, Kim SY, Shin SW, Kim CS, Choi JH, et al. Change in cancer pain management in Korea between 2001 and 2006: results of two nationwide surveys. J Pain Symptom Manage 2011;41:93-103. https://doi.org/10.1016/j.jpainsymman.2010.03.025
- Caraceni A, Martini C, Zecca E, Portenoy RK, Ashby MA, Hawson G, et al. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliat Med 2004;18:177-83. https://doi.org/10.1191/0269216304pm890oa
- Fortner BV, Okon TA, Portenoy RK. A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain. J Pain 2002;3:38-44.
- Haugen DF, Hjermstad MJ, Hagen N, Caraceni A, Kaasa S; European Palliative Care Research Collaborative (EPCRC). Assessment and classification of cancer breakthrough pain: a systematic literature review. Pain 2010;149:476-82. https://doi.org/10.1016/j.pain.2010.02.035
- Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence and characteristics. Pain 1990;41:273-81. https://doi.org/10.1016/0304-3959(90)90004-W
- Walsh D, Rivera NI, Davis MP, Lagman R, Legrand SB. Strategies for pain management: cleveland clinic foundation guidelines for opioid dosing for cancer pain. Support Cancer Ther 2004;1: 157-64. https://doi.org/10.3816/SCT.2004.n.007
- Zucco F, Bonezzi C, Fornasari D. Breakthrough cancer pain (BTcP): a synthesis of taxonomy, pathogenesis, therapy, and good clinical practice in adult patients in Italy. Adv Ther 2014;31:657-82. https://doi.org/10.1007/s12325-014-0130-z
- Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G; Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 2009;13:331-8. https://doi.org/10.1016/j.ejpain.2008.06.014
- Corli C, Pizzuto M; OICP Research Group. Per qualche dolore in meno. Capire e trattare il breakthrough cancer pain. Roma: CIC Edizioni Internazionali;2011.
- Davies A, Buchanan A, Zeppetella G, Porta-Sales J, Likar R, Weismayr W, et al. Breakthrough cancer pain: an observational study of 1000 European oncology patients. J Pain Symptom Manage 2013;46:619-28. https://doi.org/10.1016/j.jpainsymman.2012.12.009
- Portenoy RK, Bruns D, Shoemaker B, Shoemaker SA. Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 1: prevalence and characteristics. J Opioid Manag 2010;6:97-108. https://doi.org/10.5055/jom.2010.0009
- Hagen NA, Stiles C, Nekolaichuk C, Biondo P, Carlson LE, Fisher K, et al. The Alberta Breakthrough Pain Assessment Tool for cancer patients: a validation study using a delphi process and patient think-aloud interviews. J Pain Symptom Manage 2008; 35:136-52. https://doi.org/10.1016/j.jpainsymman.2007.03.016
- Sperlinga R, Campagna S, Berruti A, Laciura P, Ginosa I, Paoletti S, et al. Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain. Eur J Pain 2014 Nov 5. Epub 2014 Nov 5.
- Fainsinger RL, Nekolaichuk C, Lawlor P, Hagen N, Bercovitch M, Fisch M, et al. An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer 2010;46:2896-904. https://doi.org/10.1016/j.ejca.2010.04.017
- Caraceni A, Bertetto O, Labianca R, Maltoni M, Mercadante S, Varrassi G, et al. Episodic (breakthrough) pain prevalence in a population of cancer pain patients. Comparison of clinical diagnoses with the QUDEI--Italian questionnaire for intense episodic pain. J Pain Symptom Manage 2012;43:833-41. https://doi.org/10.1016/j.jpainsymman.2011.05.018
- Zeppetella G, Ribeiro MD. Episodic pain in patients with advanced cancer. Am J Hosp Palliat Care 2002;19:267-76. https://doi.org/10.1177/104990910201900412
- Raj SX, Thronaes M, Brunelli C, Hjermstad MJ, Klepstad P, Kaasa S. A cross-sectional study on prevalence of pain and breakthrough pain among an unselected group of outpatients in a tertiary cancer clinic. Support Care Cancer 2014;22:1965-71. https://doi.org/10.1007/s00520-014-2178-3
- Breakthrough cancer pain survey fact sheet [Internet]. Baltimore: American Pain Foundation (US); 2010. Apr 26 [cited 2015 Jan 2]. Available from: http://www.harrisinteractive.com/vault/Client_News_AmericanPainFoundation_Fact_2010_01.pdf.
- Breivik H, Cherny N, Collett B, de Conno F, Filbet M, Foubert AJ, et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol 2009;20:1420-33. https://doi.org/10.1093/annonc/mdp001
- Portenoy RK. Treatment of temporal variations in chronic cancer pain. Semin Oncol 1997;24(5 Suppl 16): S16-7-12.
- Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 2012;13:e58-68. https://doi.org/10.1016/S1470-2045(12)70040-2
- Hanks G. Oral transmucosal fentanyl citrate for the management of breakthrough pain. Eur J Palliat Care 2001;8:6-9.
- Zeppetella G, Davies AN. Opioids for the management of breakthrough pain in cancer patients. Cochrane Database Syst Rev 2013;10:CD004311.
- Bennett D, Burton AW, Fishman S, Fortner B, McCarberg B. Consensus panel recommendations for the assessment and management of breakthrough pain: Part II - management. P&T 2005;30:354-61.
- Davies AN. Breakthrough cancer pain. Curr Pain Headache Rep 2014;18:420. https://doi.org/10.1007/s11916-014-0420-9
- Current state and improvement plan of cancer pain management: focused on opioid analgesics [Internet]. Seoul: National Evidence-based Healthcare Collaborating Agency; 2012. Dec 31 [cited 2015 Jan 8]. Available from: http://www.neca.re.kr/center/researcher/report_view.jsp?boardNo=GA&seq=71&q=6 26f6172644e6f3d4741.
- Bedard G, Davies A, McDonald R, Hawley P, Buchanan A, Popovic M, et al. Breakthrough cancer pain: a comparison of surveys with European and Canadian patients. Support Care Cancer 2015;23:791-6. https://doi.org/10.1007/s00520-014-2426-6
- Jandhyala R, Fullarton JR, Bennett MI. Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials. J Pain Symptom Manage 2013;46:573-80. https://doi.org/10.1016/j.jpainsymman.2012.09.009
- Bhatnagar S, Devi S, Vinod N, Jain P, Durgaprasad G, Maroo SH, et al. Safety and efficacy of oral transmucosal fentanyl citrate compared to morphine sulphate immediate release tablet in management of breakthrough cancer pain. Indian J Palliat Care 2014;20:182-7. https://doi.org/10.4103/0973-1075.138386
- Darbà J, Kaskens L, Sanchez-de la Rosa R. Budget impact analysis of the fentanyl buccal tablet for treatment of breakthrough cancer pain. Clinicoecon Outcomes Res 2013;6:1-9.
- Yamaguchi T, Shima Y, Morita T, Hosoya M, Matoba M; Japanese Society of Palliative Medicine. Clinical guideline for pharmacological management of cancer pain: the Japanese Society of Palliative Medicine recommendations. Jpn J Clin Oncol 2013;43:896-909. https://doi.org/10.1093/jjco/hyt099
- Poulain P, Michenot N, Ammar D, Delorme C, Delorme T, Diquet B, et al. Mise au point sur l'utilisation du fentanyl transmuqueux: chez le patient présentant des douleurs d'origine canc?reuse. Douleurs Analg 2012;25:102-17. https://doi.org/10.1007/s11724-012-0287-7
- NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain Version 2. [Internet]. Washington, PA: National Comprehensive Cancer Network (US); 2014. May 11 [cited 2014 Dec 29]. Available from: http://www.nccn.org/professionals/physician_gls/pdf/pain.pdf.
- Guidelines & protocols: palliative care for the patient with incurable cancer or advanced disease - Part 2: pain and symptom management [Internet]. Victoria, B.C.: British Columbia. Ministry of Health; 2011. Sep 30 [cited 2015 Jan 5]. Available from: http://www.bcguidelines.ca/guideline_ palliative2.html.
Cited by
- Overview of the Management of Chronic Non-Cancer Pain in Patients with Spinal Disease vol.25, pp.3, 2018, https://doi.org/10.4184/jkss.2018.25.3.91
- Initial titration with 200 μg fentanyl buccal tablets: a retrospective safety analysis in Korean cancer patients vol.33, pp.3, 2018, https://doi.org/10.3904/kjim.2016.044
- Celiac Plexus Neurolysis for the Treatment of Patients with Terminal Cancer at a Tertiary University Hospital in Korea vol.23, pp.1, 2015, https://doi.org/10.14475/kjhpc.2020.23.1.5